Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
Robert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, Joanna in't Hout, Patrick C P M Verschueren, Jan H Meijerink, Frank H J van den Hoogen, Bedrich A Masek, George A W Bruyn, Jacques M G W Wouters, Alexandre E Voskuyl, Jacob M van Laar, Johannes J W Bijlsma, Désirée M F M van der Heijde, Ferdinand C Breedveld, Leo B A van de Putte, André M M Miltenburg, Filip de Keyser
Annals of the Rheumatic Diseases Sep 2010, 69 (9) 1655-1659; DOI: 10.1136/ard.2009.117234